Abstract
Aim:
Depression is a risk factor for impaired bone mass and micro-architecture, but several antidepressants were found to increase the incidence of osteoporotic fractures. In the present study we used ovariectomized (OVX) rats as a model of osteoporosis to investigate the effects of the antidepressant bupropion on the femoral bones.
Methods:
OVX animals were treated with bupropion (30, 60 mg·kg−1·d−1) for six weeks. Bone turnover biomarkers (urinary DPD/Cr ratio, serum BALP, OC, TRAcP 5b, CTX and sRANKL levels) and inflammatory cytokines (TNF-α, IL-1β and IL-6) were determined using ELISA. Inductively coupled plasma mass spectroscopy (ICP-MS) was used to determine the femoral bone mineral concentrations. The cortical and trabecular morphometric parameters of femoral bones were determined using micro-CT scan and histopathology.
Results:
In OVX rats, the levels of bone turnover biomarkers and inflammatory cytokines were significantly elevated and femoral bone Ca2+ and PO43− concentrations were significantly reduced. Moreover, cortical and trabecular morphometric parameters and histopathology of femoral bones were severely altered by ovariectomy. Bupropion dose-dependently inhibited the increases in bone turnover biomarkers and inflammatory cytokines. OVX rats treated with the high dose of bupropion showed normal mineral concentrations in femoral bones. The altered morphometric parameters and histopathology of femoral bones were markedly attenuated by the treatment.
Conclusion:
Bupropion exerts osteo-protective action in OVX rats through suppressing osteoclastogenesis-inducing factors and inflammation, which stabilize the osteoclasts and decrease bone matrix degradation or resorption.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Grases F, Sanchis P, Prieto RM, Perello J, Lopez-Gonzalez AA . Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats. J Med Food 2010; 13: 1301–6.
Potu BK, Rao MS, Nampurath GK, Chamallamudi MR, Prasad K, Nayak SR, et al. Evidence-based assessment of antiosteoporotic activity of petroleum-ether extract of Cissus quadrangularis Linn. on ovariectomy-induced osteoporosis. Ups J Med Sci 2009; 114: 140–8.
Khosla S, Westendorf JJ, Oursler MJ . Building bone to reverse osteoporosis and repair fractures. J Clin Invest 2008; 118: 421–8.
Riggs BL, Khosla S . Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279–302.
Lelovas PP, Xanthos TT, Thoma SE, Lyritis GP, Dontas IA . The laboratory rat as an animal model for osteoporosis research. Comp Med 2008; 58: 424–30.
Thompson DD, Simmons HA, Pirie CM, Ke HZ . FDA Guidelines and animal models for osteoporosis. Bone 1995; 17: 125S–133S.
Abukhadir SS, Mohamed N . Pathogenesis of alcohol-induced osteoporosis and its treatment: a review. Curr Drug Targets 2013; 14: 1601–10.
You L, Sheng ZY, Tang CL, Chen L, Pan L, Chen JY . High cholesterol diet increases osteoporosis risk via inhibiting bone formation in rats. Acta Pharmacol Sin 2011; 32: 1498–504.
Seto H, Aoki K, Kasugai S, Ohya K . Trabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in rats. Bone 1999; 25: 687–95.
Abuohashish HM, Al-Rejaie SS, Al-Hosaini KA, Parmar MY, Ahmed MM . Alleviating effects of morin against experimentally-induced diabetic osteopenia. Diabetol Metab Syndr 2013; 5: 5.
Li B, Wang Y, Liu Y, Ma J, Li Y . Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine 2013; 43: 136–46.
Schweiger U, Deuschle M, Korner A, Lammers CH, Schmider J, Gotthardt U, et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994; 151: 1691–3.
Halbreich U, Rojansky N, Palter S, Hreshchyshyn M, Kreeger J, Bakhai Y, et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995; 57: 485–91.
Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, et al. Bone mineral density in women with depression. N Engl J Med 1996; 335: 1176–81.
Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS . Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999; 159: 484–90.
Esel E, Ozsoy S, Tutus A, Sofuoglu S, Kartalci S, Bayram F, et al. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 565–70.
Mussolino ME, Jonas BS, Looker AC . Depression and bone mineral density in young adults: results from NHANES III. Psychosom Med 2004; 66: 533–7.
Whooley MA, Cauley JA, Zmuda JM, Haney EM, Glynn NW . Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 2004; 17: 88–92.
Wong SY, Lau EM, Lynn H, Leung PC, Woo J, Cummings SR, et al. Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr Os (Hong Kong). Osteoporos Int 2005; 16: 610–5.
Forsen L, Meyer HE, Sogaard AJ, Naess S, Schei B, Edna TH . Mental distress and risk of hip fracture. Do broken hearts lead to broken bones? J Epidemiol Community Health 1999; 53: 343–7.
Marques-Deak A, Cizza G, Sternberg E . Brain-immune interactions and disease susceptibility. Mol Psychiatry 2005; 10: 239–50.
Cizza G, Primma S, Csako G . Depression as a risk factor for osteoporosis. Trends Endocrinol Metab 2009; 20: 367–73.
Charney DS, Manji HK . Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004; 2004: re5.
Patterson-Buckendahl PE, Grindeland RE, Shakes DC, Morey-Holton ER, Cann CE . Circulating osteocalcin in rats is inversely responsive to changes in corticosterone. Am J Physiol 1988; 254: R828–33.
Patterson-Buckendahl P, Kvetnansky R, Fukuhara K, Cizza G, Cann C . Regulation of plasma osteocalcin by corticosterone and norepinephrine during restraint stress. Bone 1995; 17: 467–72.
Patterson-Buckendahl P, Rusnak M, Fukuhara K, Kvetnansky R . Repeated immobilization stress reduces rat vertebral bone growth and osteocalcin. Am J Physiol Regul Integr Comp Physiol 2001; 280: R79–86.
Battaglino R, Fu J, Spate U, Ersoy U, Joe M, Sedaghat L, et al. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 2004; 19: 1420–31.
Kendler KS, Karkowski LM, Prescott CA . Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999; 156: 837–41.
Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT . Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 2006; 12: 178–207.
Bredeloux P, Dubuc I, Costentin J . Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Br J Pharmacol 2007; 150: 711–9.
Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195–202.
Altschuler EL, Kast RE . Bupropion in psoriasis and atopic dermatitis: decreased tumor necrosis factor-alpha? Psychosom Med 2003; 65: 719.
Kane S, Altschuler EL, Kast RE . Crohn's disease remission on bupropion. Gastroenterology 2003; 125: 1290.
Kast RE, Altschuler EL . Bupropion and chronic aphthous ulceration. Arch Dermatol 2005; 141: 1167.
Kast RE . Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels. Gen Hosp Psychiatry 2003; 25: 495–6.
Kast RE, Altschuler EL . Remission of Crohn's disease on bupropion. Gastroenterology 2001; 121: 1260–1.
Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB . A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 2006; 6: 903–7.
Kast RE . Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities — the role of bupropion. Leuk Res 2005; 29: 1459–63.
Kaczmarczyk-Sedlak I, Folwarczna J, Trzeciak HI . Thalidomide affects the skeletal system of ovariectomized rats. Pharmacol Rep 2009; 61: 529–38.
Lee HJ, Rao JS, Chang L, Rapoport SI, Kim HW . Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? Mol Psychiatry 2010; 15: 602–14.
Reichel CM, Murray JE, Grant KM, Bevins RA . Bupropion attenuates methamphetamine self-administration in adult male rats. Drug Alcohol Depend 2009; 100: 54–62.
Shahnazari M, Martin BR, Legette LL, Lachcik PJ, Welch J, Weaver CM . Diet calcium level but not calcium supplement particle size affects bone density and mechanical properties in ovariectomized rats. J Nutr 2009; 139: 1308–14.
El-Moursy SA, Abdalla AY, El-Ashmony SM, Rashed L, Ali HHM . The effect of two selective serotonin reuptake inhibitors on the bone turnover of intact and ovariectomized female albino rats. Res J Med Med Sci 2009; 4: 136–50.
Folwarczna J, Pytlik M, Nowinska B, Cegiela U, Molin P, Hanke T, et al. Effects of selective serotonin reuptake inhibitors on bone mechanical properties in ovariectomized and non-ovariectomized rats. Bone 2009; 44: S339–S450.
Kast RE, Altschuler EL . Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha. Arch Immunol Ther Exp (Warsz) 2005; 53: 143–7.
Hertrampf T, Schleipen B, Offermanns C, Velders M, Laudenbach U, Diel P . Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats. Toxicol Lett 2009; 184: 198–203.
Choi MJ . Effects of taurine supplementation on bone mineral density in ovariectomized rats fed calcium deficient diet. Nutr Res Pract 2009; 3: 108–13.
Nian H, Ma MH, Nian SS, Xu LL . Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 2009; 16: 320–6.
Gao Q, Horvath TL . Cross-talk between estrogen and leptin signaling in the hypothalamus. Am J Physiol Endocrinol Metab 2008; 294: E817–26.
Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, et al. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis 2010; 31: 886–93.
Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S . Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 2001; 142: 4751–7.
Kim MK, Kim HD, Park JH, Lim JI, Yang JS, Kwak WY, et al. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-c yclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats. J Pharmacol Exp Ther 2006; 318: 555–62.
Gadde KM, Parker CB, Maner LG, Wagner HR 2nd, Logue EJ, Drezner MK, et al. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 2001; 9: 544–51.
Santamaria A, Arias HR . Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats. Behav Brain Res 2010; 211: 132–9.
Hou MF, Lin SB, Yuan SS, Tsai LY, Tsai SM, Hsieh JS, et al. Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients. Ann Clin Lab Sci 2003; 33: 55–61.
Samma S, Kagebayashi Y, Yasukawa M, Fukui Y, Ozono S, Hirao Y, et al. Sequential changes of urinary pyridinoline and deoxypyridinoline as markers of metastatic bone tumor in patients with prostate cancer: a preliminary study. Jpn J Clin Oncol 1997; 27: 26–30.
Sara F, Saygılı F . Causes of high bone alkaline phosphatase. Biotechnol Biotec Eq 2007; 21: 194–97.
Ross PD, Knowlton W . Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998; 13: 297–302.
Jagtap VR, Ganu JV, Nagane NS . BMD and serum intact osteocalcin in postmenopausal osteoporosis women. Indian J Clin Biochem 2011; 26: 70–3.
Ljusberg J, Wang Y, Lang P, Norgard M, Dodds R, Hultenby K, et al. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem 2005; 280: 28370–81.
Lee H, Alam M, Seol J, Kim N . Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in early stages of canine osteoarthritis. Veterinarni Medicina 2008; 53: 214–20.
Vasikaran SD . Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Crit Rev Clin Lab Sci 2008; 45: 221–58.
Kurban S, Mehmetoglu I, Gönen S, Akbulut S . Investigation of serum crosslinked N-telopeptides of type I collagen (NTx) levels and total antioxidant capacity in patients with type 2 diabetes mellitus. Turk J Biochem 2010; 35: 145–50.
Das AS, Mukherjee M, Das D, Mitra C . Protective action of aqueous black tea (Camellia sinensis) extract (BTE) against ovariectomy-induced oxidative stress of mononuclear cells and its associated progression of bone loss. Phytother Res 2009; 23: 1287–94.
Ominsky MS, Li X, Asuncion FJ, Barrero M, Warmington KS, Dwyer D, et al. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res 2008; 23: 672–82.
Boyce BF, Xing L . Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007; 9: S1.
Deal C . Potential new drug targets for osteoporosis. Nat Clin Pract Rheumatol 2009; 5: 20–7.
Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL . IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005; 115: 282–90.
Sato T, Watanabe K, Masuhara M, Hada N, Hakeda Y . Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J Bone Miner Metab 2007; 25: 19–27.
Li B, Yu S . Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull 2003; 26: 780–6.
Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T . The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 2002; 4: 281–9.
Pfeilschifter J, Koditz R, Pfohl M, Schatz H . Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90–119.
Kennedy OD, Brennan O, Rackard SM, Staines A, O'Brien FJ, Taylor D, et al. Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res 2009; 27: 303–9.
Ferretti M, Bertoni L, Cavani F, Zavatti M, Resca E, Carnevale G, et al. Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. J Anat 2010; 217: 48–56.
Sharma V, McNeill JH . To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 2009; 157: 907–21.
Reagan-Shaw S, Nihal M, Ahmad N . Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659–61.
GlaxoSmithKline. Wellbutein® Prescriping Information FDA 2004: 1–20.
Acknowledgements
The authors would like to extend their deep appreciation to the following: (1) King Abdulaziz City for Science and Technology (KACST) for funding this research work via project No (LGP-32-33), (2) Engineer Abdullah Bagshan for Growth Factors and Bone Regeneration Chair (GFBR) at King Saud University for their kind support and providing micro CT and (3) Experimental Animal Care Center, College of Pharmacy, King Saud University for the technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abuohashish, H., Ahmed, M., Al-Rejaie, S. et al. The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model. Acta Pharmacol Sin 36, 209–220 (2015). https://doi.org/10.1038/aps.2014.111
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2014.111
Keywords
This article is cited by
-
Anti-inflammatory activity of bupropion through immunomodulation of the macrophages
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
-
The potential anti-osteoporotic effect of exercise—induced increased preptin level in ovariectomized rats
Anatomical Science International (2023)
-
Nanotechnological Applications Hold a Pivotal Position in Boosting Stem Cells Osteogenic Activity: In Vitro and In Vivo Studies
Applied Biochemistry and Biotechnology (2020)
-
Osteoblast-Based Therapy—A New Approach for Bone Repair in Osteoporosis: Pre-Clinical Setting
Tissue Engineering and Regenerative Medicine (2020)
-
Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats
Journal of Orthopaedic Surgery and Research (2019)